BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Clinical Outcome
9 results:

  • 1. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
    Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
    BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tumor-associated macrophage infiltration is associated with a higher rate of tumor spread through air spaces in resected lung adenocarcinomas.
    Yoshida C; Kadota K; Ikeda T; Ibuki E; Go T; Haba R; Yokomise H
    Lung Cancer; 2021 Aug; 158():91-96. PubMed ID: 34139640
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic impact of peripheral blood neutrophil to lymphocyte ratio in advanced-stage pulmonary large cell neuroendocrine carcinoma and its association with the immune-related tumour microenvironment.
    Shirasawa M; Yoshida T; Horinouchi H; Kitano S; Arakawa S; Matsumoto Y; Shinno Y; Okuma Y; Goto Y; Kanda S; Watanabe R; Yamamoto N; Watanabe SI; Ohe Y; Motoi N
    Br J Cancer; 2021 Mar; 124(5):925-932. PubMed ID: 33250511
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer.
    Hernández-Prieto S; Romera A; Ferrer M; Subiza JL; López-Asenjo JA; Jarabo JR; Gómez AM; Molina EM; Puente J; González-Larriba JL; Hernando F; Pérez-Villamil B; Díaz-Rubio E; Sanz-Ortega J
    Clin Transl Oncol; 2015 Apr; 17(4):330-8. PubMed ID: 25301404
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky Hodgkin lymphoma.
    Hartridge-Lambert SK; Schöder H; Lim RC; Maragulia JC; Portlock CS
    Cancer; 2013 Mar; 119(6):1203-9. PubMed ID: 23132361
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic effect of stromal lymphocyte infiltration in thymic carcinoma.
    Shim HS; Byun CS; Bae MK; Lee CY; Park IK; Kim DJ; Chung KY; Lee JG
    Lung Cancer; 2011 Nov; 74(2):338-43. PubMed ID: 21492951
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence.
    Nanjundan M; Byers LA; Carey MS; Siwak DR; Raso MG; Diao L; Wang J; Coombes KR; Roth JA; Mills GB; Wistuba II; Minna JD; Heymach JV
    J Thorac Oncol; 2010 Dec; 5(12):1894-904. PubMed ID: 21124077
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma.
    Liu X; Hong XN; Gu YJ; Wang BY; Luo ZG; Cao J
    Leuk Lymphoma; 2008 Sep; 49(9):1778-83. PubMed ID: 18798110
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors.
    Igarashi T; Jiang SX; Kameya T; Asamura H; Sato Y; Nagai K; Okayasu I
    Mod Pathol; 2004 Oct; 17(10):1259-67. PubMed ID: 15154011
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.